Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles

Sinolink: Focus on Three Core Devices as Optic Modules Evolve towards High-Speed Rates and CPOadvancements.

Guosheng: PIC reshapes the optical communication industry landscape and is expected to open up the entire scene of optical interconnection space.

Guosheng: Liquid cooling transitions from expectations to mass production, opening a double inflection point for NV + CSP.
Sinolink: Focus on Three Core Devices as Optic Modules Evolve towards High-Speed Rates and CPOadvancements.

Guosheng: PIC reshapes the optical communication industry landscape and is expected to open up the entire scene of optical interconnection space.

Guosheng: Liquid cooling transitions from expectations to mass production, opening a double inflection point for NV + CSP.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


